Clinical trials
Phase 2 Immune System Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
| Recruiting | 4 |
| Terminated | 3 |
| Completed | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cogent Biosciences, Inc. | 2 |
| Alumis Inc | 1 |
| Asger Sverrild | 1 |
| AstraZeneca | 1 |
| Beeline Medicines Corporation | 1 |
| Gilead Sciences | 1 |
| Novartis Pharmaceuticals | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Queen Mary University of London | 1 |
| University of Leicester | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 13 |
| Autoimmune Diseases | 7 |
| Connective Tissue Diseases | 3 |
| Hypersensitivity | 3 |
| Glomerulonephritis | 2 |
| Glomerulonephritis, IGA | 2 |
| Hematologic Diseases | 2 |
| Immune Complex Diseases | 2 |
| Kidney Diseases | 2 |
| Lupus Erythematosus, Systemic | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.